Perspective on emerging biomarker-driven therapies in gastric cancer, FGFR2 and beyond

被引：0
|
作者：
Wainberg, Zev A. [1 ]
机构：
[1] UCLA, Ronald Reagan UCLA Med Ctr, Med Ctr, Santa Monica, CA USA
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.030
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PSY03-2
引用
收藏
页码：S1355 / S1355
页数：1
相关论文
共 50 条
  • [31] Clinical Implication of Concurrent Amplification of MET and FGFR2 in Metastatic Gastric Cancer
    Byeon, Seonggyu
    Jung, Jaeyun
    Kim, Seung Tae
    Kim, Kyoung-Mee
    Lee, Jeeyun
    BIOMEDICINES, 2023, 11 (12)
  • [32] Biomarker-Driven Therapy in Metastatic Gastric and Esophageal Cancer: Real-Life Clinical Experience
    Ofer Purim
    Alexander Beny
    Moshe Inbar
    Katerina Shulman
    Baruch Brenner
    Elizabeth Dudnik
    Felix Bokstein
    Mark Temper
    Dror Limon
    Diana Matceyevsky
    David Sarid
    Amiel Segal
    Valeriya Semenisty
    Ronen Brenner
    Tamar Peretz
    Efraim Idelevich
    Sharon Pelles-Avraham
    Amichay Meirovitz
    Arie Figer
    Kenneth Russell
    Andreas Voss
    Addie Dvir
    Lior Soussan-Gutman
    Ayala Hubert
    Targeted Oncology, 2018, 13 : 217 - 226
  • [33] Biomarker-driven immunotherapy for precision medicine in prostate cancer
    Ottini, Arianna
    Sepe, Pierangela
    Beninato, Teresa
    Claps, Melanie
    Guadalupi, Valentina
    Verzoni, Elena
    Giannatempo, Patrizia
    Baciarello, Giulia
    de Braud, Filippo
    Procopio, Giuseppe
    PERSONALIZED MEDICINE, 2022, 19 (01) : 51 - 66
  • [34] Biomarker-driven therapies for previously treated squamous non-small-cell lung cancer (Lung-MAP SWOG S1400): a biomarker-driven master protocol
    Redman, Mary W.
    Papadimitrakopoulou, Vassiliki A.
    Minichiello, Katherine
    Hirsch, Fred R.
    Mack, Philip C.
    Schwartz, Lawrence H.
    Vokes, Everett
    Ramalingam, Suresh
    Leighl, Natasha
    Bradley, Jeff
    Miao, Jieling
    Moon, James
    Highleyman, Louise
    Miwa, Crystal
    LeBlanc, Michael L.
    Malik, Shakun
    Miller, Vincent A.
    Sigal, Ellen, V
    Adam, Stacey
    Wholley, David
    Sigman, Caroline
    Smolich, Beverly
    Blanke, Charles D.
    Kelly, Karen
    Gandara, David R.
    Herbst, Roy S.
    LANCET ONCOLOGY, 2020, 21 (12): : 1589 - 1601
  • [35] Biomarker-Driven Therapy in Metastatic Gastric and Esophageal Cancer: Real-Life Clinical Experience
    Purim, Ofer
    Beny, Alexander
    Inbar, Moshe
    Shulman, Katerina
    Brenner, Baruch
    Dudnik, Elizabeth
    Bokstein, Felix
    Temper, Mark
    Limon, Dror
    Matceyevsky, Diana
    Sarid, David
    Segal, Amiel
    Semenisty, Valeriya
    Brenner, Ronen
    Peretz, Tamar
    Idelevich, Efraim
    Pelles-Avraham, Sharon
    Meirovitz, Amichay
    Figer, Arie
    Russell, Kenneth
    Voss, Andreas
    Dvir, Addie
    Soussan-Gutman, Lior
    Hubert, Ayala
    TARGETED ONCOLOGY, 2018, 13 (02) : 217 - 226
  • [36] Cancer-related FGFR2 overexpression and gene amplification in Japanese patients with gastric cancer
    Minashi, Keiko
    Yamada, Takeshi
    Hosaka, Hisashi
    Amagai, Kenji
    Shimizu, Yoshiaki
    Kiyozaki, Hirokazu
    Sato, Mikio
    Soeda, Atsuko
    Endo, Shinji
    Ishida, Hiroyasu
    Kamoshida, Toshiro
    Sakai, Yoshinori
    Shitara, Kohei
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2021, 51 (10) : 1523 - 1533
  • [37] Preclinical activity of the VEGFR, FGFR and PDGFR inhibitor lucitanib in FGFR2 aberrant endometrial and gastric cancer models
    Guffanti, F.
    Chila, R.
    Bello, E.
    Ceriani, L.
    Zangarini, M.
    Zucchetti, M.
    Saba, C.
    Jacquet-Bescond, A.
    Pierrat, M.
    Damia, G.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 110 - 110
  • [38] Expansion part of phase I study of E7090 in patients with cholangiocarcinoma harboring FGFR2 gene fusion and with gastric cancer harboring FGFR2 gene amplification or FGFR2 protein high expression
    Morizane, Chigusa
    Ueno, Makoto
    Ioka, Tatsuya
    Tajika, Masahiro
    Ikeda, Masafumi
    Yamaguchi, Kensei
    Hara, Hiroki
    Yabusaki, Hiroshi
    Miyamoto, Atsushi
    Iwasa, Satoru
    Muto, Manabu
    Takashima, Tsutomu
    Minashi, Keiko
    Komatsu, Yoshito
    Nishina, Tomohiro
    Nakajima, Takako Eguchi
    Sahara, Takatoshi
    Funasaka, Setsuo
    Yashiro, Masakazu
    Furuse, Junji
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [39] FGFR2 Gene Amplification in Gastric Cancer Predicts Sensitivity to the Selective FGFR Inhibitor AZD4547
    Xie, Liang
    Su, Xinying
    Zhang, Lin
    Yin, Xiaolu
    Tang, Lili
    Zhang, Xiuhua
    Xu, Yanping
    Gao, Zeren
    Liu, Kunji
    Zhou, Minhua
    Gao, Beirong
    Shen, Danping
    Zhang, Lianhai
    Ji, Jiafu
    Gavine, Paul R.
    Zhang, Jingchuan
    Kilgour, Elaine
    Zhang, Xiaolin
    Ji, Qunsheng
    CLINICAL CANCER RESEARCH, 2013, 19 (09) : 2572 - 2583
  • [40] Overexpression of fibroblast growth factor receptor 2 (FGFR2) in gastric cancer and basis for future FGFR2-targeted cancer therapy
    Yeh, Kun-Huei
    Shun, Chia-Tung
    Kao, Chiu-Hua
    Lin, Yu-Lin
    Shen, Ying-Chun
    Cheng, Ann-Lii
    CANCER RESEARCH, 2010, 70
12345